Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Urothelial Carcinoma of the Urinary Bladder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02101931
What this trial is testing

A Laser Detection for Bladder Cancer by (Photodynamic) Spectra of Urine

Who this might be right for
Transitional Cell Carcinoma of the Bladder
Princess Al-Johara Al-Ibrahim Cancer Research Center 100
Large-scale testing (Phase 3)Active Not RecruitingNCT04658862
What this trial is testing

TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-invasive Bladder Cancer (MIBC) of the Bladder

Who this might be right for
Urinary Bladder Neoplasms
Janssen Research & Development, LLC 518
Early research (Phase 1)Not Yet RecruitingNCT07555769
What this trial is testing

Calcium Electroporation for Urinary Bladder Tumors: A First-in-Human Feasibility, Safety, and Early Response Trial

Who this might be right for
Bladder TumorsBladder TumorUrothelial Carcinoma (UC)+1 more
Juan Luis Vásquez 20
Not applicableStudy completedNCT05799456
What this trial is testing

Glycosaminoglycan Scores as Early Detection Biomarkers in Bladder Urothelial Carcinoma

Who this might be right for
Bladder Cancer
Jens Nielsen 106
Testing effectiveness (Phase 2)Looking for participantsNCT06364956
What this trial is testing

Clinical Trail of Neoadjuvant of Tislelizumab Combined With Palbociclib in Patients With Platinum-refractory Bladder Urothelial Carcinoma

Who this might be right for
Bladder Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 36
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07639983
What this trial is testing

Multi-Omics-Based Phase Ⅱ Trial of Trastuzumab Rezetecan Plus Camrelizumab for Perioperative Therapy in HER2-Positive Muscle-Invasive Urothelial Carcinoma

Who this might be right for
Muscle-Invasive Bladder Cancer (MIBC)Urinary Bladder Cancer
Sheng Tai 44
Not applicableLooking for participantsNCT07234968
What this trial is testing

Clinical Trial to Evaluate Post-Operative Outcomes of Ureteral Stent vs Ureteral Stent Free Radical Cystectomy

Who this might be right for
Bladder CancerMuscle-Invasive Bladder CarcinomaUrothelial Carcinoma+3 more
Thomas Jefferson University 70
Testing effectiveness (Phase 2)Looking for participantsNCT04879329
What this trial is testing

Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

Who this might be right for
Urothelial Carcinoma
Seagen, a wholly owned subsidiary of Pfizer 372
Testing effectiveness (Phase 2)Study completedNCT00234039
What this trial is testing

S0353, Gemcitabine in Treating Patients With Recurrent Bladder Cancer That Has Not Responded to Previous Bacillus Calmette-Guerin

Who this might be right for
Bladder Cancer
SWOG Cancer Research Network 58
Testing effectiveness (Phase 2)Study completedNCT00080795
What this trial is testing

Neoadjuvant Ifosfamide, Doxorubicin, Gemcitabine, and Cisplatin in Treating Patients Who Are Undergoing Radical Cystectomy for Locally Advanced Carcinoma (Cancer) of the Urothelium

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
M.D. Anderson Cancer Center 65
Testing effectiveness (Phase 2)WithdrawnNCT06050954
What this trial is testing

A Pilot Study of Circulating Tumor DNA Adaptive Risk Maintenance Approach for Bladder Cancer (CARMA)

Who this might be right for
Metastatic Urothelial Carcinoma
Fox Chase Cancer Center
Early research (Phase 1)Active Not RecruitingNCT03983954
What this trial is testing

Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer.

Who this might be right for
ER+ Breast CancerOvarian CancerCervical Squamous Cell Carcinoma+17 more
NeoTX Therapeutics Ltd. 120
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07662863
What this trial is testing

Sacituzumab Tirumotecan vs MMAE-ADCs in Advanced Urothelial Carcinoma (FUSCC-SPARE-UC-01)

Who this might be right for
Bladder CancerMetastatic Urothelial CarcinomaUrothelial Carcinoma+1 more
Fudan University 75
Testing effectiveness (Phase 2)Study completedNCT05226117
What this trial is testing

Sacituzumab Govitecan, Preceding Radical Cystectomy, in Treating Patients With Muscle-invasive Bladder Cancer

Who this might be right for
Urothelial Carcinoma
IRCCS San Raffaele 44
Large-scale testing (Phase 3)Ended earlyNCT00191477
What this trial is testing

Instillation of Gemcitabine in Patients With Superficial Bladder Cancer

Who this might be right for
Bladder Neoplasms
Eli Lilly and Company 355
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07142200
What this trial is testing

A Clinical Study Evaluating the Efficacy and Safety of Disitamab Vedotin Combined With PD-1 Inhibitor and Radiotherapy as Bladder-preserving Therapy in Patients With Localized HER2-high Expressing Muscle-invasive Bladder Urothelial Carcinoma Following Maximal Transurethral Resection

Who this might be right for
Bladder (Urothelial, Transitional Cell) Cancer
RenJi Hospital 45
Testing effectiveness (Phase 2)Study completedNCT03520231
What this trial is testing

Study Comparing Denosumab With Standard Treatment in Urothelial Cancer Patients With Bone Metastases

Who this might be right for
Urothelial CarcinomaKidney CancerUreter Cancer+1 more
University Health Network, Toronto 6
Not applicableStudy completedNCT02745301
What this trial is testing

Urinary Biomarkers in the Detection of Urothelial Carcinoma of the Bladder

Who this might be right for
Bladder Cancer, Biomarkers
Vanderbilt University 50
Not applicableLooking for participantsNCT06335667
What this trial is testing

MpMRI Compared to Diagnostic TURBT in Patients With Suspected Muscle-Invasive Bladder Cancer

Who this might be right for
Urothelial Bladder CancerMuscle-Invasive Bladder Cancer
University of California, Irvine 30
Early research (Phase 1)UnknownNCT05311618
What this trial is testing

Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors

Who this might be right for
Pancreatic CancerBreast CancerGastric Cancer+13 more
NGM Biopharmaceuticals, Inc 71
Next Page